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Letter to the Editor
NEW APPROACH TO ANTI-CANCER DRUG DEVELOPMENT
SIR, There is evidence that cancer cells
have lost " product-substrate inhibition "
(Potter, 1958), a negative feedback mechan-
ism for many enzymes, by which the product
of a metabolic pathway inhibits the enzy-
matic synthesis of the product itself (Yates
and Pardee, 1956). This suggests an ap-
proach to cancer chemotherapy which, to
my knowledge, has not yet been tried.
The approach entails development of a
method to induce the synthesis of a cytotoxic
molecule via a pathway normally controlled
by feedback inhibition. Inducing synthesis of
a cytotoxic molecule might be accomplished,
e.g., by injection into the body ofa substance
which, after incorporation into an intermediate
in the pathway, renders that molecule, or a
subsequent molecule, cytotoxic.
Therapy would consist of flooding the
body with high quantities of normal pro-
duct, followed by induction of the synthesis
of the cytotoxic molecule. The high concen-
tration of normal product would inhibit
synthesis of the cytotoxic molecule in nornal
cells, but not in cancerous cells which lack
feedback inhibition. Thus, high concentra-
tions of the cytotoxic molecule would appear
selectively within cancerous cells.
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